Prime Medicine, Inc. (PRME) Net margin 2020–2025
Prime Medicine, Inc. (PRME) net profit margin by fiscal year — reported net income divided by reported revenue.
-4342.4%FY2025 · since FY2020: -65.5% → -4342.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4342.4% | +2224.2 pp |
| FY2024 | -6566.6% | — |
| FY2020 | -65.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Gross profitPRME Gross marginPRME Operating incomePRME Operating marginPRME Operating cash flowPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →